Technology M&A Advisory

M&A Advisory

Lazard

Full Credential Description

Acorda Therapeutics Inc.. United States. Announced Date 13/02/2008. Closed Date 18/02/2008. Deal value: $71m. Common stock. Industry: Acorda Therapeutics Inc. is a biotechnology company focused on developing therapies for neurological disorders.

Back to Search Contact Business